Setback to Sun Pharma as Fibromun, Nidlegy Trials Miss Key Endpoints in Cancer Studies

New Delhi: Sun Pharmaceutical Industries Limited has shared clinical updates on Fibromun and Nidlegy, with key studies failing to meet primary endpoints while further trials and regulatory pathways continue to…

Continue ReadingSetback to Sun Pharma as Fibromun, Nidlegy Trials Miss Key Endpoints in Cancer Studies

Biocon Appoints Shreehas Tambe as CEO and MD, Kedar Upadhye Named CFO Amid Business Integration

Bengaluru: Biocon Limited today announced the appointment of Shreehas Tambe as its Chief Executive Officer & Managing Director, effective April 1, 2026, following approvals from the Nomination & Remuneration Committee…

Continue ReadingBiocon Appoints Shreehas Tambe as CEO and MD, Kedar Upadhye Named CFO Amid Business Integration

AAP MP Flags Spurious Drugs Crisis, Seeks National Quality Authority as Paracetamol Fails CDSCO Tests

New Delhi: AAP MP Vikramjit Singh Sahney on Friday raised the issue of spurious medicines and expressed serious concern over the rising threat of substandard and counterfeit medicines in the…

Continue ReadingAAP MP Flags Spurious Drugs Crisis, Seeks National Quality Authority as Paracetamol Fails CDSCO Tests

Expert Panel Flags Gaps in Mascot Health’s Diabetes FDC Trial, Seeks Revised Phase IV Protocol

New Delhi: The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) on Endocrinology and Metabolism has recommended Mascot Health Series Pvt Ltd to submit a revised Phase IV…

Continue ReadingExpert Panel Flags Gaps in Mascot Health’s Diabetes FDC Trial, Seeks Revised Phase IV Protocol